EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitScoping ReviewOpen Access · CC BY-NC 4.0

Pharmacogenetics Governance for Youth Mental Health: A Scoping Review of Policy Across 13 Countries

Prosper Mandela Amaltinga Awuni iD, Bishnu B Bajgain iD, Diane L Lorenzetti iD, Gina Dimitropoulos iD, Paul D Arnold iD, Jennifer Zwicker iD, Chad Bousman iD

Clinical Pharmacology & Therapeutics · 09.11.2026

DOI: 10.1002/cpt.70562 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Pharmacology & Therapeutics, online erschienen am 09.11.2026. Verfasst von Prosper Mandela Amaltinga Awuni und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Health Policy, University of Calgary, Calgary, Alberta, Canada. Die Arbeit nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pharmacogenetics (PGx) testing could improve psychotropic prescribing for children and young people, yet youth‐specific policy guidance remains scarce. This review characterizes the international PGx policy landscape for youth mental health across 13 countries. From 940 records, 20 policy documents met inclusion criteria, yielding 190 passages for thematic analysis using the GE 3 LS framework. We found that 75% of policies primarily focused on guiding medication prescribing in adult populations, with limited consideration of youth populations; only one (5%) was designed specifically for youth. Three‐quarters of documents originated from professional organizations rather than governments, indicating a structural governance vacuum. An “inverted pyramid” of policy priorities was identified, with scientific (Genomics, 29.5%) and implementation (Social, 24.7%) considerations dominating over weak economic (7.9%) and legal (14.2%) foundations. Policy coverage primarily focused on medications used in adult populations (antidepressants 80%; cardiovascular 85%), with limited consideration of youth populations; anxiolytics, relevant in pediatric practice, were covered in only 5% of documents. Policymakers must prioritize enforceable, youth‐centered legislation to address these governance failures.

Autor:innen und Institutionen

  • School of Health Policy, University of Calgary, Calgary, Alberta, Canada.
  • Department of Medical Genetics, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
  • Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
  • Health Sciences Library, University of Calgary, Calgary, Alberta, Canada.
  • Faculty of Social Work, University of Calgary, Calgary, Alberta, Canada.
  • Department of Psychiatry, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

ORCID-Profile: Prosper Mandela Amaltinga Awuni, Bishnu B Bajgain, Diane L Lorenzetti, Gina Dimitropoulos, Paul D Arnold, Jennifer Zwicker, Chad Bousman

Zitieren

APA

Awuni, P. M. A., Bajgain, B. B., Lorenzetti, D. L., Dimitropoulos, G., Arnold, P. D., Zwicker, J., & Bousman, C. (2026). Pharmacogenetics Governance for Youth Mental Health: A Scoping Review of Policy Across 13 Countries. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.70562

Vancouver

Awuni PMA, Bajgain BB, Lorenzetti DL, Dimitropoulos G, Arnold PD, Zwicker J, et al. Pharmacogenetics Governance for Youth Mental Health: A Scoping Review of Policy Across 13 Countries. Clinical Pharmacology & Therapeutics. 2026. doi:10.1002/cpt.70562

BibTeX
@article{Awuni2026,
  author = {Awuni, Prosper Mandela Amaltinga and Bajgain, Bishnu B and Lorenzetti, Diane L and Dimitropoulos, Gina and Arnold, Paul D and Zwicker, Jennifer and Bousman, Chad},
  title = {Pharmacogenetics Governance for Youth Mental Health: A Scoping Review of Policy Across 13 Countries},
  journal = {Clinical Pharmacology & Therapeutics},
  year = {2026},
  doi = {10.1002/cpt.70562}
}
Kostenlos starten →